Stem Cells Application in Eye Regeneration and Restoration of Vision

  • Living reference work entry
  • First Online:
Handbook of Stem Cell Applications

Abstract

Eye tissues mostly comprise terminally differentiated cells or limited sets of stem cells with little potential for differentiation and regeneration. Eye damage in humans is irreversible, and eye transplantation is not the most feasible option to restore eyesight for individuals who have lost vision from various underlying causes of tissue damage, autoimmunity, and genetic anomalies. In most cases, vision loss arises from partial damage to eye tissue. Stem cell transplantation and eye tissue genesis have emerged as tools to correct specific damage and can be an ideal therapeutic approach to restoring vision and repairing damaged tissues. Interestingly, iPSCs, ESCs, MSCs, and lab-grown tissue organoids can pave the foundation for the restoration of vision among individuals with inherited rare genetic disorders and those who succumbed to accidental vision loss arising from the damaged cornea, lens, retina, retinal pigmental epithelia, and optic nerves. Overcoming regulatory compliances, soon lab-grown organoids, and technological advances for growing eye cells in mass potentiate the idea of stem cell–guided therapeutics for accidental and hereditary blindness.

RSM conceived the idea and wrote the chapter. AM, SA, AJ, NMA, AN, and ADP participated in the discussion and wrote the chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Abbreviations

AMD:

Age-related macular degeneration

ANGPTL4:

Angiopoietin-like 4

AS:

Ankylosing spondylitis

BM_MSCs:

Bone marrow–derived MSCs

CD:

Crohn’s disease

CNS:

Central nervous system

DME:

Diabetic macular edema

ERG:

Electroretinography

ESCs:

Embryonic stem cells

iPSC:

Induced pluripotent stem cell

iPSCs:

Induced pluripotent stem cells

M.08:

Near visual acuity measurement

MSCs:

Mesenchymal stem cells

N6:

Near visual acuity at 40 cm

NPDR:

Nonproliferative diabetes related retinopathy

OCT:

Optical coherence tomography

OKR:

Optokinetic response

PDR:

Proliferative diabetes related retinopathy

POU4F2:

POU Class 4 Homeobox 2

RGCs:

Retinal ganglion cells

RP:

Retinitis pigmentosa

RPE:

Retinal pigment epithelium

SIX6:

SIX Homeobox 6

UC:

Ulcerative colitis

VEGF:

Vascular endothelial growth factor

VIP:

Vasoactive intestinal peptide

XLRP:

X-linked retinitis pigmentosa

References

Download references

Acknowledgments

RSM is an Oxford BMS Fellow. SA is funded by the Clarendon scholarship, St John’s College, and AJ is funded by the Clarendon scholarship and Exeter College, University of Oxford. NMA is funded by the Industrial Cooperative Award in Science and Engineering (ICASE) training grant in collaboration with Vertex Pharmaceuticals and the Reuben Foundation. The figure illustrations were created using Biorender.com. There is no funding source involved in this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ranjeet Singh Mahla .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Singapore Pte Ltd.

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Mahla, R.S. et al. (2023). Stem Cells Application in Eye Regeneration and Restoration of Vision. In: Haider, K.H. (eds) Handbook of Stem Cell Applications. Springer, Singapore. https://doi.org/10.1007/978-981-99-0846-2_65-1

Download citation

  • DOI: https://doi.org/10.1007/978-981-99-0846-2_65-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-99-0846-2

  • Online ISBN: 978-981-99-0846-2

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics

Navigation